本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Compass Therapeutics, Inc.

3.00
-0.1500-4.76%
盘后3.010.0100+0.33%19:04 EDT
成交量:66.25万
成交额:202.14万
市值:4.15亿
市盈率:-7.49
高:3.22
开:3.20
低:2.97
收:3.15
数据加载中...
2021/03/05

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/01/14

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/17

重要事件披露

8-K - Current report
2020/11/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/19

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/09/23

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/18

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/15

重要事件披露

8-K - Current report
2020/08/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/08/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/31

重要事件披露

8-K/A [Amend] - Current report
2020/07/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/26

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/26

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/23

重要事件披露

8-K - Current report